This inventor holds 1 USPTO granted patent. Top assignee: Wakamoto Pharmaceutical Co., Ltd.. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Masahiko Wakasugi: Innovator in Diagnostic Methods
Introduction
Masahiko Wakasugi is a prominent inventor based in Tokyo, Japan. He is known for his significant contributions to the field of immunoassay methods, particularly in the development of diagnostic kits that are both cost-effective and user-friendly. His work has the potential to revolutionize the way infections are diagnosed, making it accessible to a broader audience.
Latest Patents
Wakasugi holds a patent for a monoclonal antibody hybridoma immunoassay method and diagnosis kit. The objective of this invention is to provide a diagnostic method that allows for the diagnosis of infections at a low cost, without causing pain to subjects and without the need for specialized equipment. This method is designed to be free of cross-reactivity and exhibits excellent specificity, ensuring consistent quality control. The monoclonal antibody developed by Wakasugi recognizes catalase as an antigen, demonstrating good sensitivity even when a single antibody is utilized. He has 1 patent to his name.
Career Highlights
Wakasugi is associated with Wakamoto Pharmaceutical Co., Ltd., where he continues to innovate and contribute to the field of diagnostics. His work is characterized by a commitment to improving healthcare through advanced technology and research.
Collaborations
Wakasugi has collaborated with notable colleagues, including Ritsuko Mochida and Haruhisa Hirata, to further enhance the impact of his inventions in the medical field.
Conclusion
Masahiko Wakasugi's contributions to diagnostic methods exemplify the importance of innovation in healthcare. His work not only addresses the need for effective diagnostic tools but also emphasizes the significance of accessibility and specificity in medical testing.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
